{
    "id": 16882,
    "fullName": "FANCA S1088F",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "FANCA S1088F lies within the leucine zipper domain of the Fanca protein (PMID: 22194614). S1088F results in a loss of Fanca protein function as indicated by decreased Fancd2 and Fanci monoubiquitination, and decreased DNA repair in response to mitomycin C treatment in culture (PMID: 28864460).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 13321,
                    "pubMedId": 22194614,
                    "title": "Fanconi anemia complementation group A (FANCA) protein has intrinsic affinity for nucleic acids with preference for single-stranded forms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22194614"
                },
                {
                    "id": 10575,
                    "pubMedId": 28864460,
                    "title": "A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28864460"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2175,
        "geneSymbol": "FANCA",
        "terms": [
            "FANCA",
            "FA",
            "FA-H",
            "FA1",
            "FAA",
            "FACA",
            "FAH",
            "FANCH"
        ]
    },
    "variant": "S1088F",
    "createDate": "01/19/2016",
    "updateDate": "09/28/2019",
    "referenceTranscriptCoordinates": {
        "id": 163303,
        "transcript": "NM_000135",
        "gDna": "chr16:g.89748744G>A",
        "cDna": "c.3263C>T",
        "protein": "p.S1088F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12681,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of FANCA S1088F in FANCA-null cells derived from Fanconi anemia patients resulted in increased sensitivity to Platinol (cisplatin) compared to wild-type Fanca expression in culture (PMID: 28864460).",
            "molecularProfile": {
                "id": 17161,
                "profileName": "FANCA S1088F"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10575,
                    "pubMedId": 28864460,
                    "title": "A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28864460"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12682,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of FANCA S1088F in FANCA-null cells derived from Fanconi anemia patients resulted in increased sensitivity to Lynparza (olaparib) in culture, and a patient-derived xenograft (PDX) model of prostate cancer harboring germline FANCA S1088F demonstrated enhanced sensitivity to Lynparza (olaparib) treatment (PMID: 28864460).",
            "molecularProfile": {
                "id": 17161,
                "profileName": "FANCA S1088F"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10575,
                    "pubMedId": 28864460,
                    "title": "A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28864460"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 17161,
            "profileName": "FANCA S1088F",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 163303,
            "transcript": "NM_000135",
            "gDna": "chr16:g.89748744G>A",
            "cDna": "c.3263C>T",
            "protein": "p.S1088F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 163304,
            "transcript": "NM_001286167",
            "gDna": "chr16:g.89748744G>A",
            "cDna": "c.3263C>T",
            "protein": "p.S1088F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 163305,
            "transcript": "XM_005256294",
            "gDna": "chr16:g.89748744G>A",
            "cDna": "c.3263C>T",
            "protein": "p.S1088F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}